| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; 1:500; loading ...; fig 3c
| de Cubas A, Dunker W, Zaninovich A, Hongo R, Bhatia A, Panda A, et al. DNA hypomethylation promotes transposable element expression and activation of immune signaling in renal cell cancer. JCI Insight. 2020;5: pubmed publisher |
- immunocytochemistry; mouse; 1:1000; loading ...; fig 6c
| Adapala N, Swarnkar G, Arra M, Shen J, Mbalaviele G, Ke K, et al. Inflammatory osteolysis is regulated by site-specific ISGylation of the scaffold protein NEMO. elife. 2020;9: pubmed publisher |
- western blot; human; 1:1000; loading ...; fig 4b
| Chiang C, Pauli E, Biryukov J, Feister K, Meng M, White E, et al. The Human Papillomavirus E6 Oncoprotein Targets USP15 and TRIM25 To Suppress RIG-I-Mediated Innate Immune Signaling. J Virol. 2018;92: pubmed publisher |
- immunocytochemistry; human; fig 1B
- western blot; human; fig 1A
| Kim Y, Kim E, Kim Y, Lee M, Kwon K, Kim K, et al. Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators. PLoS Pathog. 2016;12:e1005850 pubmed publisher |
| Gilda J, Ghosh R, Cheah J, West T, Bodine S, Gomes A. Western Blotting Inaccuracies with Unverified Antibodies: Need for a Western Blotting Minimal Reporting Standard (WBMRS). PLoS ONE. 2015;10:e0135392 pubmed publisher |
| Cottrell K, Ryu S, Torres L, Schab A, Weber J. Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells. bioRxiv. 2023;: pubmed publisher |
| Yamashita N, Fushimi A, Morimoto Y, Bhattacharya A, Hagiwara M, Yamamoto M, et al. Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer. Cancers (Basel). 2022;14: pubmed publisher |
| Chu Z, Gu L, Hu Y, Zhang X, Li M, Chen J, et al. STAG2 regulates interferon signaling in melanoma via enhancer loop reprogramming. Nat Commun. 2022;13:1859 pubmed publisher |
| Hagiwara M, Fushimi A, Bhattacharya A, Yamashita N, Morimoto Y, Oya M, et al. MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer. Oncoimmunology. 2022;11:2029298 pubmed publisher |
| Williams G, Gokhale N, Snider D, Horner S. The mRNA Cap 2'-O-Methyltransferase CMTR1 Regulates the Expression of Certain Interferon-Stimulated Genes. mSphere. 2020;5: pubmed publisher |
| Liu R, Olano L, Mirzakhanyan Y, Gershon P, Moss B. Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation. Cell Rep. 2019;29:816-828.e6 pubmed publisher |
| He C, Lv X, Huang C, Angeletti P, Hua G, Dong J, et al. A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis. Cell Rep. 2019;26:2636-2650.e5 pubmed publisher |
| Radoshevich L, Impens F, Ribet D, Quereda J, Nam Tham T, Nahori M, et al. ISG15 counteracts Listeria monocytogenes infection. elife. 2015;4: pubmed publisher |
